Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for Tuberculosis in HIV Infection
NCT00057421Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone in Tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 1998; status: completed.
02
Drugs
prednisolone
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00057421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057421.